Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials
It's been hard paying for it on my teacher's salary (my insurance won't cover it), but it's been worth it
It is not a GLP-1 medication, will not produce GLP-1 medication-level effects, and is not a substitute for medical care if you have serious health concerns
10.1016/j.lfs.2015.12.033 74 VivarelliF.GranataS.RulloL.MussoniM.CandelettiS.RomualdiP.et al (2022)
[2] [3] Based on the known class effects of GLP-1 and GIP receptor agonists, the following additional cautions are relevant, even where retatrutide-specific data are still emerging: Acute pancreatitis : Participants should be advised to seek urgent medical attention if they develop severe, persistent abdominal pain particularly pain radiating to the back accompanied by vomiting, as this may indicate pancreatitis